SEC Filings :: Propanc Biopharma, Inc. (PPCB)

Q3 2017

Latest Quarterly Results
Ended March 31, 2017

View Financials

Research and development YTD

Net cash used in operations YTD

10-K • September 28, 2017

Annual report pursuant to Section 13 and 15(d)

8-K • October 2, 2017

Current report filing

DEF 14C • March 13, 2017

Definitive information statements

View and filter by group or type